Suspension of trading

Income Statement Assertio Holdings

Stocks

ASRT

US04546C3043

Pharmaceuticals

Market Closed - Nasdaq 00:00:00 16/06/2026 +04			5-day change	1st Jan Change
23.50 ^USD	+0.09%		-.--%	+159.10%

06-17	Assertio Holdings Completes Merger With Zydus Lifesciences	MT
06-17	Assertio Holdings, Inc. Announces Board and Committee Changes, Effective June 16, 2026	CI

ad56c.ZNqTv-Cu34081eSaFkM8cvwnzsMJ7anWKm1Zd7sUb8Y.A5_7z9b7qdVftJTyQDF4Joxv-49Mhp2AYjkWMopEK5EMjtDRr8yO6HiY1A

Published financial data: ASSERTIO HOLDINGS

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Revenues	112M	158M	152M	123M	119M
Other Revenues, Total	-985K	-1.29M	185K	2.1M	-
Total Revenues	111M	156M	152M	125M	119M
Cost of Goods Sold, Total	15.23M	17.95M	27.02M	39.23M	35.38M
Gross Profit	95.78M	138M	125M	85.73M	83.33M
Selling General & Admin Expenses, Total	47.63M	48.1M	69.74M	76.95M	69M
R&D Expenses	-	-	2.84M	3.82M	1.69M
Amortization of Goodwill and Intangible Assets - (IS)	28.11M	32.61M	27.53M	25.64M	29.86M
Other Operating Expenses	-	-	-	-	-
Other Operating Expenses, Total	75.75M	80.71M	100M	106M	101M
Operating Income	20.04M	57.57M	24.94M	-20.68M	-17.22M
Interest Expense, Total	-10.22M	-7.96M	-3.38M	-3.04M	-3.08M
Interest And Investment Income	-	-	-	3.22M	2.66M
Net Interest Expenses	-10.22M	-7.96M	-3.38M	182K	-410K
Other Non Operating Income (Expenses)	834K	-960K	-7.14M	2.76M	180K
EBT, Excl. Unusual Items	10.65M	48.65M	14.42M	-17.74M	-17.45M
Restructuring Charges	-1.09M	-	-5.48M	-720K	-2.89M
Merger & Related Restructuring Charges	-600K	-800K	-8.9M	-	-
Impairment of Goodwill	-	-	-	-	-
Gain (Loss) On Sale Of Investments	-	-	-	-	-
Gain (Loss) On Sale Of Assets	-	-	-	-	-8.17M
Asset Writedown	-	-	-280M	-5.22M	-1.7M
In Process R&D Expenses	-	-	-	-	-
Insurance Settlements	5M	2M	-	1.9M	-
Legal Settlements	-10.6M	-	-	-	-
Other Unusual Items	-3.91M	-18.69M	25.54M	244K	276K
EBT, Incl. Unusual Items	-553K	31.17M	-254M	-21.53M	-29.94M
Income Tax Expense	728K	-78.46M	77.89M	52K	435K
Earnings From Continuing Operations	-1.28M	110M	-332M	-21.58M	-30.38M
Net Income to Company	-1.28M	110M	-332M	-21.58M	-30.38M
Net Income - (IS)	-1.28M	110M	-332M	-21.58M	-30.38M
Net Income to Common Incl Extra Items	-1.28M	110M	-332M	-21.58M	-30.38M
Net Income to Common Excl. Extra Items	-1.28M	110M	-332M	-21.58M	-30.38M
Per Share Items
Net EPS - Basic	-0.45	34.98	-70.1	-3.4	-4.74
Basic EPS - Continuing Operations	-0.45	34.98	-70.1	-3.4	-4.74
Basic Weighted Average Shares Outstanding	2.88M	3.13M	4.74M	6.35M	6.4M
Net EPS - Diluted	-0.45	30.51	-70.1	-3.45	-4.74
Diluted EPS - Continuing Operations	-0.45	30.51	-70.1	-3.45	-4.74
Diluted Weighted Average Shares Outstanding	2.88M	3.64M	4.74M	6.35M	6.4M
Normalized Basic EPS	2.31	9.7	1.9	-1.75	-1.7
Normalized Diluted EPS	2.31	8.34	1.9	-1.75	-1.7
Supplemental Items
EBITDA	49.11M	90.97M	53.17M	5.15M	12.78M
EBITA	48.15M	90.18M	52.47M	4.96M	12.64M
EBIT	20.04M	57.57M	24.94M	-20.68M	-17.22M
EBITDAR	48.86M	90.45M	53.4M	5.4M	13.02M
Total Revenues (As Reported)	111M	156M	152M	125M	119M
Effective Tax Rate - (Ratio)	-131.65	-251.75	-30.66	-0.24	-1.45
Current Domestic Taxes	511K	1.92M	1.69M	52K	435K
Total Current Taxes	511K	1.92M	1.69M	52K	435K
Deferred Domestic Taxes	217K	-80.38M	76.2M	-	-
Total Deferred Taxes	217K	-80.38M	76.2M	-	-
Normalized Net Income	6.66M	30.41M	9.01M	-11.08M	-10.91M
Interest on Long-Term Debt	10.22M	7.96M	3.38M	3.04M	3.08M
Supplemental Operating Expense Items
Advertising Expense	1.8M	3.4M	4.4M	1.8M	1.3M
Selling and Marketing Expenses	1.8M	3.4M	4.4M	1.8M	1.3M
Research And Development Expense From Footnotes	-	-	2.84M	3.82M	1.69M
Net Rental Expense, Total	-250K	-524K	229K	256K	241K
Imputed Operating Lease Interest Expense	-247K	-466K	114K	153K	147K
Imputed Operating Lease Depreciation	-2.94K	-57.72K	115K	103K	93.74K
Stock-Based Comp., COGS (Total)	-	-	-	-	-
Stock-Based Comp., R&D Exp. (Total)	-	-	-	-	-
Stock-Based Comp., SG&A Exp. (Total)	3.54M	7.5M	9.16M	5.01M	3.45M
Stock-Based Comp., Other (Total)	-	-	-	-	-
Total Stock-Based Compensation	3.54M	7.5M	9.16M	5.01M	3.45M

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Assets
Cash And Equivalents	36.81M	64.94M	73.44M	50.59M	10.23M
Short Term Investments	-	-	-	49.47M	53.18M
Total Cash And Short Term Investments	36.81M	64.94M	73.44M	100M	63.4M
Accounts Receivable, Total	44.36M	45.36M	47.66M	54.12M	120M
Other Receivables	-	-	-	-	-
Total Receivables	44.36M	45.36M	47.66M	54.12M	120M
Inventory	7.49M	13.7M	37.69M	38.31M	24.12M
Prepaid Expenses	14.84M	8.27M	11.97M	9.76M	8.67M
Other Current Assets, Total	-	-	299K	303K	344K
Total Current Assets	103M	132M	171M	203M	217M
Gross Property Plant And Equipment	14.01M	4.81M	6.67M	5.11M	4.95M
Accumulated Depreciation	-11.75M	-3.93M	-4.63M	-3.4M	-3.54M
Net Property Plant And Equipment	2.26M	881K	2.04M	1.71M	1.42M
Long-term Investments	1.58M	268K	-	-	-
Other Intangibles, Total	216M	198M	111M	80.47M	48.91M
Accounts Receivable Long-Term	-	-	-	-	-
Deferred Tax Assets Long-Term	-	80.2M	-	-	-
Other Long-Term Assets, Total	3.15M	2.3M	1.99M	1K	1K
Total Assets	327M	414M	286M	285M	267M
Liabilities
Accounts Payable, Total	6.68M	5.99M	13.44M	14.74M	9.01M
Accrued Expenses, Total	66.53M	61.61M	71.97M	93.96M	111M
Current Portion of Long-Term Debt	12.17M	470K	-	-	-
Current Portion of Leases	1.98M	401K	928K	331K	240K
Current Income Taxes Payable	-	-	-	-	-
Unearned Revenue Current, Total	300K	200K	-	-	-
Other Current Liabilities	47.35M	26.65M	7.1M	5.66M	7.01M
Total Current Liabilities	135M	95.32M	93.44M	115M	128M
Long-Term Debt	61.32M	66.4M	38.51M	38.81M	39.12M
Long-Term Leases	397K	-	1.47M	1.12M	889K
Other Non Current Liabilities	27.4M	26.47M	14.99M	9.03M	5.49M
Total Liabilities	224M	188M	148M	164M	173M
Common Stock, Total	4K	5K	9K	9K	1K
Additional Paid In Capital	532M	545M	790M	794M	797M
Retained Earnings	-429M	-320M	-652M	-673M	-703M
Comprehensive Income and Other	-	-	-	-	-
Total Common Equity	102M	226M	138M	121M	93.95M
Total Equity	102M	226M	138M	121M	93.95M
Total Liabilities And Equity	327M	414M	286M	285M	267M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	3.02M	3.71M	6.33M	6.38M	6.45M
ECS Total Common Shares Outstanding	2.98M	3.22M	6.31M	6.37M	6.42M
Book Value / Share	34.41	70.07	21.87	19.01	14.63
Tangible Book Value	-114M	27.73M	26.67M	40.61M	45.04M
Tangible Book Value Per Share	-38.19	8.61	4.23	6.38	7.01
Total Debt	75.87M	67.27M	40.91M	40.27M	40.25M
Net Debt	39.06M	2.33M	-32.53M	-59.79M	-23.15M
Debt Equivalent Oper. Leases	-2M	-4.19M	1.83M	2.05M	1.93M
Account Code - Inventory Valuation	8	8	8	8	8
Inventories - Raw Materials, Total	1.24M	1.37M	10.54M	15.52M	15.17M
Inventories - Work In Process, Total	823K	2.74M	2.24M	4.9M	6.05M
Inventories - Finished Goods, Total	5.42M	9.59M	24.91M	17.88M	2.9M
Machinery, Total	2.75M	1.73M	1.93M	1.43M	1.43M
Full Time Employees	19	30	53	58	53

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Net Income	-1.28M	110M	-332M	-21.58M	-30.38M
Depreciation & Amortization - CF	963K	788K	702K	185K	142K
Amortization of Goodwill and Intangible Assets - (CF)	28.11M	32.61M	27.53M	25.64M	29.86M
Depreciation & Amortization, Total	29.08M	33.4M	28.23M	25.83M	30M
Amortization of Deferred Charges, Total - (CF)	194K	304K	455K	439K	475K
(Gain) Loss From Sale Of Asset	-	-	-	-	8.17M
Asset Writedown & Restructuring Costs	-	-	280M	5.22M	1.7M
Stock-Based Compensation (CF)	3.54M	7.5M	9.16M	5.01M	3.45M
Tax Benefit from Stock Options	-	-	-	-	-
Other Operating Activities, Total	5.28M	-59.22M	63.92M	6.29M	3.72M
Change In Accounts Receivable	-11K	-996K	48.67M	-6.46M	-65.99M
Change In Inventories	4.27M	-6.59M	-4.97M	-9.58M	9.68M
Change In Accounts Payable	-28.7M	-10.21M	-29.35M	-1.26M	-13.29M
Change In Income Taxes	522K	-	-	-	-
Change in Other Net Operating Assets	-7.37M	4.78M	-14.21M	22.5M	24.27M
Cash from Operations	5.52M	78.6M	49.6M	26.41M	-28.18M
Capital Expenditure	-18.52M	-274K	-628K	-	-
Sale of Property, Plant, and Equipment	-	-	-	-	-
Cash Acquisitions	-	-	1.95M	-	-
Divestitures	-	-	-	-	-8.17M
Sale (Purchase) of Intangible assets	-	-42.4M	-419K	-	-
Investment in Marketable and Equity Securities, Total	-	-	2.19M	-48.91M	-3.81M
Other Investing Activities, Total	-	-	-	-	-
Cash from Investing	-18.52M	-42.67M	3.1M	-48.91M	-11.99M
Long-Term Debt Issued, Total	-	70M	-	-	-
Total Debt Issued	-	70M	-	-	-
Long-Term Debt Repaid, Total	-9.84M	-70.75M	-10.5M	-	-
Total Debt Repaid	-9.84M	-70.75M	-10.5M	-	-
Issuance of Common Stock	45.05M	7.05M	-	-	-
Repurchase of Common Stock	-418K	-872K	-7.9M	-350K	-189K
Other Financing Activities, Total	-5.78M	-13.23M	-25.8M	-	-
Cash from Financing	29.03M	-7.79M	-44.2M	-350K	-189K
Net Change in Cash	16.02M	28.13M	8.5M	-22.85M	-40.36M
Supplemental Items
Cash Interest Paid	10.12M	7.75M	3.65M	2.6M	2.6M
Cash Income Tax Paid (Refund)	-	-6.91M	4.03M	1.59M	142K
Levered Free Cash Flow	30.01M	2.48M	18.04M	33.42M	-16.58M
Unlevered Free Cash Flow	36.21M	7.16M	19.7M	34.88M	-15.14M
Change In Net Working Capital	-9.59M	27.06M	32.23M	-16.97M	37.83M
Net Debt Issued / Repaid	-9.84M	-750K	-10.5M	-	-

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Profitability
Return on Assets	3.98	9.72	4.45	-4.53	-3.9
Return on Total Capital	7.74	15.27	6.61	-7.6	-7.28
Return On Equity %	-1.62	66.82	-182.52	-16.66	-28.25
Return on Common Equity	-1.62	66.82	-182.52	-16.66	-28.25
Margin Analysis
Gross Profit Margin %	86.28	88.51	82.23	68.61	70.19
SG&A Margin	42.91	30.79	45.86	61.58	58.12
EBITDA Margin %	44.24	58.23	34.96	4.12	10.77
EBITA Margin %	43.37	57.72	34.5	3.97	10.65
EBIT Margin %	18.05	36.85	16.4	-16.55	-14.51
Income From Continuing Operations Margin %	-1.15	70.17	-218.28	-17.27	-25.59
Net Income Margin %	-1.15	70.17	-218.28	-17.27	-25.59
Net Avail. For Common Margin %	-1.15	70.17	-218.28	-17.27	-25.59
Normalized Net Income Margin	6	19.46	5.93	-8.87	-9.19
Levered Free Cash Flow Margin	27.03	1.59	11.86	26.74	-13.97
Unlevered Free Cash Flow Margin	32.61	4.58	12.95	27.91	-12.75
Asset Turnover
Asset Turnover	0.35	0.42	0.43	0.44	0.43
Fixed Assets Turnover	33.37	99.42	104.16	66.65	75.95
Receivables Turnover (Average Receivables)	2.53	3.54	3.27	2.41	1.36
Inventory Turnover (Average Inventory)	1.59	1.69	1.05	1.03	1.13
Short Term Liquidity
Current Ratio	0.77	1.39	1.83	1.77	1.7
Quick Ratio	0.6	1.16	1.3	1.34	1.44
Operating Cash Flow to Current Liabilities	0.04	0.82	0.53	0.23	-0.22
Days Sales Outstanding (Average Receivables)	144.55	103.24	111.77	151.6	267.85
Days Outstanding Inventory (Average Inventory)	230.05	215.41	347.05	354.52	321.99
Average Days Payable Outstanding	356.3	95.77	69.51	129.39	204.5
Cash Conversion Cycle (Average Days)	18.31	222.88	389.3	376.74	385.34
Long Term Solvency
Total Debt/Equity	74.08	29.8	29.65	33.26	42.84
Total Debt / Total Capital	42.56	22.96	22.87	24.96	29.99
LT Debt/Equity	60.26	29.42	28.97	32.98	42.59
Long-Term Debt / Total Capital	34.62	22.66	22.35	24.75	29.81
Total Liabilities / Total Assets	68.64	45.47	51.82	57.48	64.81
EBIT / Interest Expense	1.96	7.23	7.38	-6.81	-5.6
EBITDA / Interest Expense	4.9	11.44	15.8	1.78	4.24
(EBITDA - Capex) / Interest Expense	3.08	11.4	15.61	1.78	4.24
Total Debt / EBITDA	1.52	0.74	0.77	7.45	3.09
Net Debt / EBITDA	0.78	0.03	-0.61	-11.07	-1.78
Total Debt / (EBITDA - Capex)	2.41	0.74	0.78	7.45	3.09
Net Debt / (EBITDA - Capex)	1.24	0.03	-0.62	-11.07	-1.78
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	2.72	40.73	-2.67	-17.83	-5
Gross Profit, 1 Yr. Growth %	3.77	44.38	-9.05	-31.44	-2.8
EBITDA, 1 Yr. Growth %	-401.73	81	-41.03	-90.32	81.41
EBITA, 1 Yr. Growth %	-368.62	82.93	-41.3	-90.54	84.23
EBIT, 1 Yr. Growth %	-146.91	171.78	-56.07	-182.93	-8.31
Earnings From Cont. Operations, 1 Yr. Growth %	-95.45	-8.66K	-402.8	-93.5	40.75
Net Income, 1 Yr. Growth %	-95.45	-8.66K	-402.8	-93.5	40.75
Normalized Net Income, 1 Yr. Growth %	-117.61	356.84	-69.86	-222.97	10.21
Diluted EPS Before Extra, 1 Yr. Growth %	-97.21	-6.88K	-329.78	-95.08	39.61
Accounts Receivable, 1 Yr. Growth %	0.02	3.67	5.08	13.55	121.93
Inventory, 1 Yr. Growth %	-36.06	82.88	175.16	1.65	-37.04
Net Property, Plant and Equip., 1 Yr. Growth %	-48.5	-61.05	131.44	-16.09	-17.3
Total Assets, 1 Yr. Growth %	7.67	26.75	-30.8	-0.59	-6.24
Tangible Book Value, 1 Yr. Growth %	-21.39	-124.4	-3.82	52.26	10.92
Common Equity, 1 Yr. Growth %	84.48	120.4	-38.86	-12.26	-22.41
Cash From Operations, 1 Yr. Growth %	-108.42	1.32K	-36.89	-46.76	-206.72
Capital Expenditures, 1 Yr. Growth %	185K	416.98	129.2	-	-
Levered Free Cash Flow, 1 Yr. Growth %	-92.09	-91.92	809.25	85.24	-147.92
Unlevered Free Cash Flow, 1 Yr. Growth %	-90.56	-80.62	195.96	77.07	-141.96
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-30.45	20.23	17.04	-10.57	-11.65
Gross Profit, 2 Yr. CAGR %	-34.02	22.4	14.26	-21.03	-18.37
EBITDA, 2 Yr. CAGR %	-29.15	136.41	2.85	-76.11	-50.97
EBITA, 2 Yr. CAGR %	-29.42	124.3	3.16	-76.44	-50.92
EBIT, 2 Yr. CAGR %	97.97	16.11	8.51	-39.64	-16.9
Earnings From Cont. Operations, 2 Yr. CAGR %	-92.32	97.36	1.51K	-55.63	-69.75
Net Income, 2 Yr. CAGR %	-92.32	97.36	1.51K	-55.63	-69.75
Normalized Net Income, 2 Yr. CAGR %	-56.46	-10.3	16.37	-39.12	10
Diluted EPS Before Extra, 2 Yr. CAGR %	-95.06	37.62	1.15K	-66.37	-73.99
Accounts Receivable, 2 Yr. CAGR %	2.22	1.13	4.37	9.23	58.74
Inventory, 2 Yr. CAGR %	48.15	8.14	124.33	67.24	-20
Net Property, Plant and Equip., 2 Yr. CAGR %	-39.95	-55.21	-5.06	39.36	-16.7
Total Assets, 2 Yr. CAGR %	-21.3	16.83	-6.35	-17.06	-3.45
Tangible Book Value, 2 Yr. CAGR %	-42.4	-56.2	-51.55	21.02	29.96
Common Equity, 2 Yr. CAGR %	32.93	101.65	16.08	-26.76	-17.49
Cash From Operations, 2 Yr. CAGR %	-75.29	9.48	199.69	-42.04	-24.62
Capital Expenditures, 2 Yr. CAGR %	253.67	423.45	244.22	-	-
Levered Free Cash Flow, 2 Yr. CAGR %	-47.25	-91.91	-23.38	310.4	-4.13
Unlevered Free Cash Flow, 2 Yr. CAGR %	-45.21	-86.34	-26.96	128.92	-12.34
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-24.32	-12.03	12.06	4.02	-8.75
Gross Profit, 3 Yr. CAGR %	-26.13	-14.34	10.65	-3.63	-15.37
EBITDA, 3 Yr. CAGR %	-33.56	-2.4	48.38	-53.22	-47.86
EBITA, 3 Yr. CAGR %	-33.74	-2.29	43.05	-53.49	-47.9
EBIT, 3 Yr. CAGR %	-32.01	124.15	-16.41	-0.79	-32.81
Earnings From Cont. Operations, 3 Yr. CAGR %	-67.38	-20.38	127.63	156.35	-34.81
Net Income, 3 Yr. CAGR %	-67.38	-20.38	127.63	156.35	-34.81
Normalized Net Income, 3 Yr. CAGR %	39.31	-4.68	-37.98	18.53	-28.55
Diluted EPS Before Extra, 3 Yr. CAGR %	-76.39	-45.09	63.26	97.18	-46.23
Accounts Receivable, 3 Yr. CAGR %	6.15	2.23	2.43	7.35	38.35
Inventory, 3 Yr. CAGR %	30.16	58.93	47.63	72.3	20.76
Net Property, Plant and Equip., 3 Yr. CAGR %	-44.26	-48.02	-22.57	-8.89	17.11
Total Assets, 3 Yr. CAGR %	-29.52	-7.75	-1.89	-4.46	-13.6
Tangible Book Value, 3 Yr. CAGR %	-37.78	-56.74	-43.07	-29.04	17.55
Common Equity, 3 Yr. CAGR %	-22.54	57.33	35.47	5.74	-25.34
Cash From Operations, 3 Yr. CAGR %	-57.61	-4.58	-8.88	68.47	-28.96
Capital Expenditures, 3 Yr. CAGR %	49.84	-43.02	297.48	-	-
Levered Free Cash Flow, 3 Yr. CAGR %	-3.14	-71.55	-63.77	2.84	102.94
Unlevered Free Cash Flow, 3 Yr. CAGR %	-12.59	-61	-62.83	-1.88	31.5
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-24.61	-16.32	-9.9	-11.45	1.9
Gross Profit, 5 Yr. CAGR %	-23.62	-14.81	-12.05	-17.18	-2.02
EBITDA, 5 Yr. CAGR %	-18.16	-0.6	-20.5	-44.51	-4.72
EBITA, 5 Yr. CAGR %	-18.17	-0.17	-20.53	-44.78	-6.75
EBIT, 5 Yr. CAGR %	-3.85	37.44	-17.11	32.25	-16.61
Earnings From Cont. Operations, 5 Yr. CAGR %	-57.15	1.35	55.16	-36.99	1.54
Net Income, 5 Yr. CAGR %	-57.15	1.35	55.16	-36.99	1.54
Normalized Net Income, 5 Yr. CAGR %	-28.96	-10.48	29.64	-20.59	-22
Diluted EPS Before Extra, 5 Yr. CAGR %	-65.11	-20.83	15.43	-54.87	-21.69
Accounts Receivable, 5 Yr. CAGR %	-15.44	-8.81	5.14	4.97	22.05
Inventory, 5 Yr. CAGR %	-10.49	0.98	61.82	62.2	15.54
Net Property, Plant and Equip., 5 Yr. CAGR %	-31.97	-41.65	-31.03	-22.88	-20.27
Total Assets, 5 Yr. CAGR %	-23.24	-16.81	-21.03	-11.59	-2.52
Tangible Book Value, 5 Yr. CAGR %	-29.48	-46.36	-43.71	-34.72	-20.8
Common Equity, 5 Yr. CAGR %	-16.4	5.9	-8.93	15.88	11.1
Cash From Operations, 5 Yr. CAGR %	-40.04	4.8	-7.31	-21.83	-15.54
Capital Expenditures, 5 Yr. CAGR %	45.3	-16.28	-35.22	-	-
Levered Free Cash Flow, 5 Yr. CAGR %	-18.27	-53.21	-11.39	-20.89	-46.53
Unlevered Free Cash Flow, 5 Yr. CAGR %	-20.91	-44.62	-18.33	-21.97	-47.61